A case–control study in a Han Chinese population provided evidence that the GG genotype and G carrier (CG + GG) of rs2228314 G > C polymorphism in SREBP-2 may increase the risk of NAFLD. The gene discussed is SREBF2; the disease is metabolic dysfunction-associated steatotic liver disease.